| scholarly article | Q13442814 |
| P2093 | author name string | Laurence Bernard-Demanze | |
| Michel Lacour | |||
| Brahim Tighilet | |||
| Isabelle Watabe | |||
| Jacques Léonard | |||
| P2860 | cites work | Neuropharmacology of vestibular system disorders | Q24624927 |
| Betahistine for symptoms of vertigo | Q26471456 | ||
| Interaction between Vestibular Compensation Mechanisms and Vestibular Rehabilitation Therapy: 10 Recommendations for Optimal Functional Recovery | Q26825937 | ||
| Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors | Q28338480 | ||
| Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) | Q28602238 | ||
| Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor | Q34249836 | ||
| A mechanism of central compensation of vestibular function following hemilabyrinthectomy. | Q51226711 | ||
| Neuronal activity in the ipsilateral vestibular nucleus following unilateral labyrinthectomy in the alert guinea pig. | Q51590373 | ||
| Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow. | Q53441843 | ||
| Betahistine metabolites, aminoethylpyridine, and hydroxyethylpyridine increase cochlear blood flow in guinea pigs in vivo. | Q53836613 | ||
| Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness | Q53875138 | ||
| Neurochemical mechanisms of recovery from peripheral vestibular lesions (vestibular compensation) | Q67801789 | ||
| Mechanisms of recovery following unilateral labyrinthectomy: a review | Q69520016 | ||
| [Compensation deficits in posture and kinetics following unilateral vestibular neurectomy in cats. The role of sensorimotor activity] | Q70713465 | ||
| Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat | Q72145042 | ||
| Effect of unilateral vestibular stimulation on histamine release from the hypothalamus of rats in vivo | Q72741908 | ||
| High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series | Q84230069 | ||
| Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss | Q85183953 | ||
| Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo | Q34321223 | ||
| Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action | Q34432126 | ||
| Pharmacological treatment of vertigo | Q35042682 | ||
| Molecular mechanisms of brainstem plasticity. The vestibular compensation model | Q36472967 | ||
| Modulation of histamine synthesis and release in brain via presynaptic autoreceptors and heteroreceptors | Q36601233 | ||
| Plastic events in the vestibular nuclei during vestibular compensation: the brain orchestration of a "deafferentation" code | Q37677975 | ||
| Mechanisms of vestibular compensation: recent advances | Q37778719 | ||
| Pharmacology of balance and dizziness | Q38104546 | ||
| Neuropharmacological basis of vestibular system disorder treatment | Q38157561 | ||
| Recovery of head postural control following unilateral vestibular neurectomy in the cat. Neck muscle activity and neuronal correlates in Deiters' nuclei | Q38567525 | ||
| BDNF Signaling Promotes Vestibular Compensation by Increasing Neurogenesis and Remodeling the Expression of Potassium-Chloride Cotransporter KCC2 and GABAA Receptor in the Vestibular Nuclei | Q39699187 | ||
| 'Vestibular compensation': neural plasticity and its relations to functional recovery after labyrinthine lesions in frogs and other vertebrates | Q40418328 | ||
| Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease | Q40698894 | ||
| Antivertigo medications and drug-induced vertigo. A pharmacological review | Q40961261 | ||
| Autoregulation of histamine release in brain by presynaptic H3-receptors | Q42228591 | ||
| Neuronal activity in the vestibular nuclei after contralateral or bilateral labyrinthectomy in the alert guinea pig. | Q42464106 | ||
| Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat. | Q42485327 | ||
| Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms | Q44050769 | ||
| New insights into vestibular neuropharmacology: from bench to bedside | Q44366552 | ||
| Stress axis plasticity during vestibular compensation in the adult cat. | Q46088953 | ||
| Vestibular compensation revisited | Q46148407 | ||
| Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial | Q46637476 | ||
| Effect of drug therapy on compensation from vestibular injury | Q46944892 | ||
| Histaminergic ligands improve vestibular compensation in the cat: behavioural, neurochemical and molecular evidence | Q48134433 | ||
| Responses of hypothalamic neurons to stimulation of the vestibular nerve and lateral vestibular nucleus in the rabbit | Q48256713 | ||
| Medial vestibular nucleus in the guinea-pig: histaminergic receptors. I. An in vitro study | Q48368564 | ||
| Modifications and development of spinal reflexes in the alert baboon (Papio papio) following an unilateral vestibular neurotomy | Q48369549 | ||
| Sequential [(18)F]FDG µPET whole-brain imaging of central vestibular compensation: a model of deafferentation-induced brain plasticity | Q48504273 | ||
| Changes in the histaminergic system during vestibular compensation in the cat. | Q48585081 | ||
| Histamine immunoreactivity changes in vestibular-lesioned and histaminergic-treated cats | Q48660648 | ||
| Histamine release from the hypothalamus induced by gravity change in rats and space motion sickness | Q48699633 | ||
| Role of capillary pericytes and precapillary arterioles in the vascular mechanism of betahistine in a guinea pig inner ear model | Q48743204 | ||
| Distribution of histaminergic axonal fibres in the vestibular nuclei of the cat. | Q49053023 | ||
| Histamine depolarizes rat medial vestibular nucleus neurons recorded intracellularly in vitro | Q49098441 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pharmacokinetics | Q323936 |
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 431 | |
| P577 | publication date | 2018-06-11 | |
| P1433 | published in | Frontiers in Neurology | Q15817039 |
| P1476 | title | Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches. | |
| P478 | volume | 9 |
Search more.